This may be surprising since ERβ inhibits the proliferative activity of ERα (38) and RASFF1 is a tumor suppressor gene whose inactivation by hypermethylation of a CpG island in the gene promoter (39) has been implicated in a wide variety of sporadic human cancers, including breast cancer (20). Here, ESR2 is linked to breast carcinoma.